Navigation Links
Advance in bowel cancer test research
Date:6/9/2009

Australian researchers have developed gene expression biomarkers which can accurately discriminate pre-cancerous and cancerous colorectal growths from non-cancerous controls.

Being presented today at the Digestive Disease Week conference in Chicago, the preliminary findings are the result of a collaborative study involving CSIRO, Flinders University and Australian healthcare company, Clinical Genomics Pty Ltd designed to develop an improved screening/diagnostic test for detecting bowel cancer and significant pre-cancer lesions.

"If we can now show that the levels of these biomarkers in blood or stool also correlate strongly with disease state in a large group of patients with cancer or pre-cancer lesions (ie adenomatous polyps) we may have the basis for a very important new diagnostic weapon in the fight against bowel cancer," says CSIRO's Preventative Health National Research Flagship Theme Leader in Colorectal Cancer and Gut Health, Dr Trevor Lockett.

According to Professor Graeme Young from Flinders University's Centre for Cancer Prevention and Control, regular screening for bowel cancer in people aged 50 years and over is a powerful tool for reducing the impact of the disease in Australia.

"If we can develop a screening test that can point to the presence of clinically important pre-cancerous adenomas which are then removed during follow-up colonoscopy, we will actually be able to prevent the occurrence of bowel cancer in some cases," Professor Young says.

The CEO of Clinical Genomics Pty Ltd, Lawrence La Pointe, says if a more robust screening test for bowel cancer and especially pre-cancer lesions emerges, the research team will have achieved a major advance likely to further improve screening outcomes and more precisely identify those people most likely to benefit from colonoscopic investigation.


'/>"/>

Contact: Kelly Golding
kelly.golding@csiro.au
045-850-3304
CSIRO Australia
Source:Eurekalert  

Page: 1

Related medicine news :

1. Advances in Medical Technology Identified as a Primary Driver of Increased Costs
2. New interdisciplinary volume focuses on advances in stem cell research
3. In Both the U.S. and Mexico, we Must Advance not Retreat From Strategic Government Goals Regarding Drug Addiction and Drug-Related Crime, Says Narconon International
4. IMAGINE Software Unveils Advanced IMAGINEradiology(TM) Features
5. MEDRAD Introduces Manage.Report - Advances Evidence-Based Decision Making
6. I-SPY trial offers key insights into locally advanced breast cancer
7. Vaccine shows therapeutic promise against advanced melanoma
8. Lumenis(R) Presents the SlimLine(TM) GI Laser Fiber: The Latest Advancement in Laser Lithotripsy for Gastroenterology
9. Study shows drug combination improves outcome for advanced non-small cell lung cancer
10. Chemo Alone Is Best for Advanced Colon Cancer
11. 1 in 10 advanced colon cancer patients worry about prescription drug costs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Advance in bowel cancer test research
(Date:3/29/2015)... 29, 2015 At this initial ... provides basic health information around medical conditions that ... these challenges as well as helping them find ... six medical conditions using evidenced based information in ... in conversations around them., , ...
(Date:3/29/2015)... North American Seminars receives Texas Board Physical Therapy ... . , Utilizing Pilates to Enhance Rehab ... # 56399TX      , The Interactive Shoulder Algorithm ... 10.5 hours - Texas Board of Physical Therapy      ... the SI Joint - 10 hours - Texas Board ...
(Date:3/28/2015)... March 28, 2015 Coffee could not only ... protect you from gum disease, researchers have found. , They ... disease. , Coffee contains antioxidants. Antioxidants fight gum disease. Does ... researchers at Boston Univ. Henry M. Goldman School of Dental ... August 2014 issue of the Journal of Periodontology. , “This ...
(Date:3/28/2015)... March 28, 2015 Take a bite ... kicks into action. Acids tumble into the stomach, ready ... faulty valve-like structure lets these acids run amok, triggering ... extremely common symptom. More than 60 million Americans have ... examine where heartburn starts, and how it can be ...
(Date:3/28/2015)... California-based leading wig brand UniWigs has prepared a mysterious ... the Easter Holidays from today until April 6th. There ... Day. , As the winter fades and spring approaches, ... with religious origins to countries in Europe and the ... best wig provider, UniWigs, would like to offer a ...
Breaking Medicine News(10 mins):Health News:Krame Health Solutions Announces Release of AfroHealthLink, an Interactive Health Resource Center Tailored to Individuals of African & Caribbean Descent Around the World 2Health News:Krame Health Solutions Announces Release of AfroHealthLink, an Interactive Health Resource Center Tailored to Individuals of African & Caribbean Descent Around the World 3Health News:New Research Impliments Coffee May Help Fight Gum Disease and Increasing Benefits With Tylers Coffee 2Health News:Bypass Your Heartburn Worries This Easter With Tylers Coffee 2Health News:UniWigs Is Sending Out Mysterious Gifts During the Easter Holidays 2
... MORRISVILLE, Pa., Feb. 13 As the FDA ... risk evaluation and mitigation plans for extended release ... chronic pain have already discovered a resource that ... treatments. Emerging Solutions in Pain ( ...
... do more to promote awareness, study says , , FRIDAY, Feb. ... by name or role -- the doctors assigned to their ... , "The majority of hospitalized patients we looked at were ... said study author Dr. Vineet Arora, associate program director at ...
... national survey conducted by the Harvard Opinion Research Program at ... majority (93%) of Americans have heard or read about the ... aware of the recall, about six in ten (61%) say ... risk of getting sick from contaminated peanut products. Specifically, about ...
... YORK, Feb. 13 In a bid to help ... online auction of the Ysio Digital Radiology System, donated ... at $99,999 and jumped to a quarter million dollars ... Siemens (NYSE: SI ) at: , ...
... are under way , , FRIDAY, Feb. 13 (HealthDay ... Chinese medicine may be able to control allergic reactions ... City,s Mount Sinai School of Medicine report. , Food ... allergies among children have increased 18 percent since 1997, ...
... Corporation (Nasdaq: DYNT ) today announced results for ... 2008. Operating results showed significant improvement over the three and ... quarter ended December 31, 2008, improved to $89,917, compared to ... the prior fiscal year. Net income for the quarter ended ...
Cached Medicine News:Health News:Opioid Safety and Efficacy Web Resource for Clinicians Supports Education and Practice Needs 2Health News:Opioid Safety and Efficacy Web Resource for Clinicians Supports Education and Practice Needs 3Health News:Many Hospital Patients Can't ID Their Doctors 2Health News:Many Hospital Patients Can't ID Their Doctors 3Health News:Following peanut product recall, six in ten Americans taking steps to reduce risk of sickness 2Health News:Following peanut product recall, six in ten Americans taking steps to reduce risk of sickness 3Health News:Herbal Remedy Could Halt Peanut Allergy 2Health News:Herbal Remedy Could Halt Peanut Allergy 3Health News:Dynatronics Reports Profitable Second Quarter - Signaling Significant Improvement Over Prior Year Results 2Health News:Dynatronics Reports Profitable Second Quarter - Signaling Significant Improvement Over Prior Year Results 3Health News:Dynatronics Reports Profitable Second Quarter - Signaling Significant Improvement Over Prior Year Results 4
(Date:3/27/2015)... Holdings, Inc. (NYSE and SIX: ZMH) is celebrating a key milestone in ... Knee System. ,   ... introduced the NexGen knee system, with its innovative design and ... of the NexGen knee have taken place worldwide. ... the importance of design innovation and component quality for surgeons and patients ...
(Date:3/27/2015)... 27, 2015 CHINA ... Senior Care, Rehabilitation Medicine and Healthcare, second to none ... will be held at Shanghai New International Expo Center ... 2015,  Implementation Suggestions on Encouraging Private Capital to Participate ... was jointly issued by the Ministry of Civil Affairs of ...
(Date:3/27/2015)... According to a new market ... Advanced, Ultrasound), Ablation Catheter (Cryoablation, RF, Microwave), Lab Devices ... WPW) - Global Forecasts to 2019 ", published by MarketsandMarkets, ... ~$4.73 Billion by 2019 with a CAGR of around ... Browse   90   ma rket ...
Breaking Medicine Technology:Zimmer Celebrates Key Milestones For NexGen Complete Knee System 2CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 2CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 3CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 4CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 5CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 6Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4
... Alcon, Inc. (NYSE: ACL ) and its ... today that Alcon has begun treating patients in a Phase ... for viral conjunctivitis, a type of "pink eye". Conjunctivitis ... and children, leading to more than four million doctor and ...
... and BRISTOL, Tenn., July 2 Acura Pharmaceuticals, Inc. (Nasdaq: ... KG ) announced today that the U.S. Food and ... the New Drug Application (NDA) for Acurox (oxycodone HC1, USP ... for the relief of moderate-to-severe pain. , ...
Cached Medicine Technology:Alcon Commences Phase 2 Clinical Trial of NovaBay's NVC-422 for Viral Conjunctivitis 2Alcon Commences Phase 2 Clinical Trial of NovaBay's NVC-422 for Viral Conjunctivitis 3Alcon Commences Phase 2 Clinical Trial of NovaBay's NVC-422 for Viral Conjunctivitis 4Acura and King Receive FDA Complete Response Letter Regarding Acurox(R) 2Acura and King Receive FDA Complete Response Letter Regarding Acurox(R) 3
The ADx system uses fluorescence polarization immunoassay technology for the detection of abused drugs and toxicology assays....
Innotrac Aio! immunoanalyzers are specially designed to exploit the benefits of Innotrac Diagnostics' exclusive dry chemistry and non-enhancement time-resolved fluorometry....
... The Access immunoassay system ... access benchtop analyzer that ... assays, with panels that ... thyroid, infectious disease, blood ...
...
Medicine Products: